Meadow Creek Investment Management’s Mohawk Industries MHK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.69M Sell
13,608
-3,388
-20% -$435K 0.03% 359
2019
Q2
$2.51M Buy
16,996
+7,952
+88% +$1.1M 0.05% 299
2019
Q1
$1.14M Buy
9,044
+3,276
+57% +$427K 0.02% 433
2018
Q4
$675K Buy
5,768
+1,400
+32% +$187K 0.02% 527
2018
Q3
$766K Buy
4,368
+868
+25% +$170K 0.02% 558
2018
Q2
$750K Buy
3,500
+616
+21% +$135K 0.02% 510
2018
Q1
$670K Sell
2,884
-504
-15% -$130K 0.01% 530
2017
Q4
$934K Buy
3,388
+672
+25% +$180K 0.02% 467
2017
Q3
$672K Sell
2,716
-280
-9% -$69.7K 0.02% 517
2017
Q2
$724K Buy
2,996
+84
+3% +$19.8K 0.02% 492
2017
Q1
$668K Buy
2,912
+140
+5% +$30.8K 0.02% 472
2016
Q4
$553K Buy
+2,772
New +$544K 0.01% 495

Other funds holding MHK

Meadow Creek Investment Management's MHK Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Mohawk Industries (MHK) stake by 20% in Q3 2019, selling an estimated $435K and leaving 13,608 shares worth $1.69M. The position accounts for 0.03% of the portfolio, ranked #359.

Meadow Creek Investment Management first reported a position in MHK in Q4 2016 and has held it in 12 quarters since. The position peaked at $2.51M in Q2 2019. 451 funds tracked by Wall St. Rank hold MHK as of Q3 2019.

  • Meadow Creek Investment Management held 13,608 shares of Mohawk Industries worth $1.69M as of Q3 2019.
  • Meadow Creek Investment Management sold 3,388 Mohawk Industries shares in Q3 2019, an estimated $435K.
  • Mohawk Industries made up 0.03% of Meadow Creek Investment Management's portfolio in Q3 2019, its #359 holding.
  • Meadow Creek Investment Management first reported a position in Mohawk Industries in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Mohawk Industries position peaked at $2.51M in Q2 2019.
  • 451 funds tracked by Wall St. Rank held Mohawk Industries as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.